Pinar Özden Eser PhD Eli and Edythe L. Broad Institute of MIT and Harvard 2025 LCRF | Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer
Paul Stockhammer MD, PhD Yale University 2025 LCRF | Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer
Elizabeth Brunk PhD The University of North Carolina at Chapel Hill 2025 LCRF – Boehringer Ingelheim Early Investigator Award on Innovative Approaches Toward the Treatment of HER2-Driven Lung Cancer
Dongsung Kim PhD Ohio State University 2025 LCRF Research Grant on Overcoming Resistance in Lung Cancer
Ximeng Liu PhD University of Texas MD Anderson Cancer Center 2025 LCRF Research Grant on Overcoming Resistance in Lung Cancer
Patricia Pereira PhD Washington University School of Medicine in St. Louis 2025 LCRF Leading Edge Research Grant Program
Xiuning Le MD, PhD University of Texas MD Anderson Cancer Center 2025 LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations
Sarah Goldberg MD, MPH Yale School of Medicine 2025 LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations